Sunshine Biopharma (SBFM) Asset Writedowns and Impairment (2025)

Sunshine Biopharma's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $131788.0 for Q4 2025.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $131788.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
• Asset Writedowns and Impairment was $131788.0 for Q4 2025 at Sunshine Biopharma, down from $554650.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $1.1 million in Q2 2025 and bottomed at $131788.0 in Q4 2025.